Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002005 · ClinicalTrials.gov registry record · NA
A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex
A NA study, sponsored by Genentech.
- Completed
- Registry status
- NA
- Development phase
NCT00002005 is a NA study that has completed, run by Genentech.
The verdict
NCT00002005, a NA study, has completed, sponsored by Genentech.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To determine the safety profile and maximum tolerated dose (MTD) of recombinant soluble human CD4 (rCD4) therapy in patients with AIDS or AIDS related complex (ARC). To obtain a preliminary indication of the antiviral effects of rCD4 in patients with AIDS and ARC. To measure steady state serum levels of rCD4 following continuous infusion therapy.
Interventions
- DRUG CD4 Antigens
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002005
The ClinicalTrials.gov registry entry for NCT00002005 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Genentech, which has 332 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CD4 Antigens is the first listed.
NCT00002005 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002005 about?
NCT00002005 is a clinical study titled "A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex". To determine the safety profile and maximum tolerated dose (MTD) of recombinant soluble human CD4 (rCD4) therapy in patients with AIDS or AIDS related complex (ARC). To obtain a preliminary indication of the antiviral effects of rCD4 in patients with AIDS and ARC. To measure steady state serum level...
What is the current status of trial NCT00002005?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002005?
The interventions under investigation include: CD4 Antigens (DRUG).
Who is sponsoring clinical trial NCT00002005?
This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.